The advent of next-generation sequencing (NGS) now allows a detailed assessment of the adaptive immune system in health and disease. In particular, high-throughput B-cell receptor (BCR) repertoire sequencing provides detailed information about the functionality and abnormalities of the B-cell system. However, it is mostly unknown how the BCR repertoire is altered in the context of primary immunodeficiencies (PID) and whether findings are consistent throughout phenotypes and genotypes. We have performed an extensive literature search of the published work on BCR repertoire sequencing in PID patients, including several forms of predominantly antibody disorders and combined immunodeficiencies. It is somewhat surprising that BCR repertoires, even from severe clinical phenotypes, often show only mild abnormalities and that diversity or immunoglobulin gene segment usage is generally preserved to some extent. Despite the great variety of wet laboratory and analytical methods that were used in the different studies, several findings are common to most investigated PIDs, such as the increased usage of gene segments that are associated with self-reactivity. These findings suggest that BCR repertoire characteristics may be used to assess the functionality of the B-cell compartment irrespective of the underlying defect. With the use of NGS approaches, there is now the opportunity to apply BCR repertoire sequencing to multiple patients and explore the PID BCR repertoire in more detail. Ultimately, using BCR repertoire sequencing in translational research could aid the management of PID patients by improving diagnosis, estimating functionality of the immune system and improving assessment of prognosis.
Introduction
B-cells are key players of the adaptive immune system and mediate humoral immunity through the production of antibodies. As a critical aspect of the adaptive immune system, B-cells also provide memory responses by generating more rapid and stronger responses upon subsequent encounter with a previously met antigen.
1 Each B-cell expresses a unique membrane-bound antibody or B-cell receptor (BCR). The variety of BCRs generated in an individual must be sufficient for the immune system to recognize a large number of different antigens. This enormous variation is generated through DNA recombination of different BCR variable (V), diversity (D) and joining (J) genes (known as the VDJ recombination). 2 Diversity is increased at the joining junctions by the addition of palindromic (P) and non-templated (N) nucleotides, and potential nucleotide deletion mediated by exonuclease activity. 3 Following antigen encounter and interaction with T follicular helper (Tfh) cells, BCRs are further diversified through somatic hypermutation. 4 The sum of all BCRs in an individual or sample is called the BCR repertoire. The function of an immune system in terms of mechanisms of diversification and adequate response to antigens can be seen in the characteristics of the BCR repertoire.
The main effector function of B-cells is the generation of a broad range of antibodies able to protect against infection. Other parts of the innate and adaptive immune system, such as antigen-presenting and Tfh cells, also need to function efficiently and interact with B-cells to generate a diverse and functional BCR repertoire upon antigen stimulation. 5 There is an important balance between generating sufficient B-cell diversity to allow the recognition of a wide array of foreign antigens and ensuring the removal of B-cells which produce pathogenic selfreactive antibodies capable of causing autoimmune diseases. In a well-functioning system there are a number of mechanisms, which act mainly during B-cell development in the bone marrow, to decrease the frequency of such self-reactive B-cells in the primary BCR repertoire. 6 Patients with primary immunodeficiency (PID) manifest with a variety of clinical syndromes including increased susceptibility to infection, autoimmune and autoinflammatory disease and malignancy. PIDs are a heterogeneous group of conditions, some of which will cause little problem, and others with the potential for severe manifestations such as invasive infections. Disorders affecting antibody production account for the majority of registered PIDs. 7, 8 These defects are diagnosed using a combination of clinical features and laboratory immunology testing, which usually includes the assessment of total and specific immunoglobulin concentrations. 9, 10 Antibody disorders can be associated with a variety of laboratory abnormalities, ranging from isolated reductions in certain immunoglobulin isotypes or poor immune responses to specific antigens to reductions in all immunoglobulin isotypes, reduced responses to all antigens and low numbers of B-cell subpopulations. 11 Currently available diagnostic tests provide a relatively limited view of the function of the B-cell system in individual patients, and this limits optimal clinical management and the ability to determine prognosis. For example, some individuals with low immunoglobulin (Ig) G levels may be asymptomatic from the viewpoint of infection burden, and there are examples of symptomatic patients with susceptibility to infection similar to those with antibody deficiencies who have normal immunoglobulin levels and numbers of B-cells. Furthermore, currently used methods to assess B-cell function, such as stimulating an individual's immune system through vaccination followed by measuring the immune response, are limited to a small number of antigens and findings are often difficult to interpret. 12 Hence, there is a need for better diagnostic techniques that accurately classify immunodeficient patients according to their individual disease risk.
Until a few years ago, BCR sequencing techniques with low throughput or limited resolution, such as Sanger sequencing of individual B-cells or complementaritydetermining region 3 (CDR3) spectratyping, permitted only a basic assessment of the BCR repertoire. In contrast, recent advances in next-generation sequencing (NGS) now allow unprecedented insight into the characteristics of an individual's BCR repertoire by providing rapid and accurate high-throughput and deep sequencing at low cost. 13 Using BCR repertoire sequencing, critical repertoire characteristics such as diversity, mutation rate and the distribution of sequences across isotype subclass can now be assessed in detail. [14] [15] [16] The relationship between the characteristics of the BCR repertoire and clinical phenotype has not yet been systematically assessed for a wide range of PIDs. Abnormal routine laboratory findings are likely to reflect defects in the mechanisms of diversification and selection of the BCR repertoire (hence leading to alterations in the B-cell phenotype). Alterations in repertoire characteristics have previously been found in a limited number of different PIDs, and may therefore be used to identify functional defects in the B-cell compartment and improve our understanding of antibody disorders but also defects that affect other parts of the immune system but result in dysfunctional B-cell responses.
In this review, we summarize studies that have used BCR repertoire sequencing for the investigation of PID patients. We also discuss how the findings from these studies can lead to an improved understanding of the disease, and ultimately, how the use of this technology has the potential for improving patient management (Fig. 1) .
Use of BCR repertoire sequencing in patients with PID
PIDs can be split into disorders of the innate and adaptive immune system, with the latter further subdividing into humoral (B-cell or antibody) and cellular (T-cell) defects (Fig. 2) . Predominantly antibody disorders (PAD) are by far the most common form of PID 7, 8 and are characterized by an isolated or predominant B-cell defect without evidence of profound T-cell deficiency. 17 Combined immunodeficiencies (CID) are primarily T-cell disorders which affect both the B-and T-cell systems and vary in terms of the severity of clinical phenotype. 17 Here, we summarize the findings from BCR repertoire studies of PID patients and have divided these into studies of individuals with predominant B-cell disorders (PAD) and those with disorders of the T-cell system (CID) ( Table 1 ).
Predominantly antibody disorders
Early studies evaluated the BCR repertoire in patients with X-linked agammaglobulinaemia (XLA) as an example of a severe and isolated B-cell defect. 18 These studies were mainly undertaken before Bruton's tyrosine kinase (BTK) was found to be defective in XLA, and were used to explore the hypothesis that defective BCR gene rearrangement was the cause for the observed B-cell differentiation arrest in XLA.
Five early studies used small numbers of B-cell lines or cDNA clones to determine the structure and diversity of BCR sequences derived from XLA patients. [19] [20] [21] [22] [23] Overall, the results from these studies indicate that, for such a profound disorder, there is a surprisingly diverse and productive array of heavy and light chain BCR rearrangement of the few residual B-cells in XLA. However, given the small number of mainly naive B-cell-derived BCR sequences that were studied and the lack of adequate control sequences, it remained unclear whether the BCR repertoire from XLA patients is truly different from that of healthy controls (HC 
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NEW TOOLS AND APPLICATIONS OF IMMUNE RECEPTOR PROFILING BY HIGH-THROUGHPUT SEQUENCING BCR repertoire sequencing in PID patients phenotypes, the cause of the disease is still unknown in the majority of cases. [28] [29] [30] The immunological defects underlying CVID have been investigated in an older study by Levy et al. 31 examining the mutation rate of BCRs from peripheral blood B-cells in CVID and hypogammaglobulinaemic patients. In this study, despite the small number of sequences analysed, two of the CVID cases were shown to have limited somatic hypermutation, with a large proportion of their memory B-cells expressing VH genes with no mutation from germline. The other four CVID patients had evidence of almost normal somatic hypermutation. In another study, IJspeert et al. 32 analysed the naive BCR repertoire in previously described CVID patients. 33 There was no difference in any of the studied BCR repertoire characteristics (CDR3 length and composition and BCR diversity) between patients and HCs. Based on these observations, the authors concluded that there were no qualitative defects in the naive repertoire of the studied CVID patients. In a recent large study, Roskin et al. 34 explored BCR repertoire properties in CVID by conducting high-throughput sequencing of BCR rearrangements in total B-cells and in naive and memory B-cells. Of importance, this study included 93 patients and 105 controls which gave significant power to see differences in repertoire characteristics. CDR3 length analysis of B-cell subsets showed impaired selection against longer CDR3 segments in the na€ ıve and memory B-cells of CVID patients compared with those of HC. In addition, CVID patients showed a decreased diversity of the naive BCR repertoire, decreased somatic hypermutation in memory BCR repertoires and an abnormal expansion of unmutated B-cell clonal families. In contrast, clonal families isolated from HC samples consisted of mutated memory B-cells. Overall, the available BCR repertoire data in CVID patients are in line with the heterogeneity of the disease and generally show lower levels of somatic hypermutation, decreased repertoire diversity and longer CDR3 segments.
Autosomal-recessive CD19 and CD21 deficiency are very rare forms of PAD caused by a maturation defect and are clinically categorized as hypogammaglobulinaemia or CVID. [35] [36] [37] [38] Van Zelm et al. 39 analysed the BCR repertoire of CD19-deficient patients and found reduced somatic hypermutation in both IgA and IgG transcripts and preferential usage of IgA1 and IgG1/3 subclasses. IGHV3/4 gene family usage was diverse, but there was impaired selection against BCR sequences with self-reactive features. 40 These features included an increased VH4-34 gene usage and isotype-switched transcripts with significantly longer CDR3 segments which were seen in patients compared with controls. CD19-deficient patients also showed a decreased transition to transversion ratio for isotypeswitched transcripts than did HC, and displayed evidence of increased base excision repair and reduced mismatch repair activity. Wentink et al. 38 studied IgA and IgG BCR transcripts in a 13-year-old boy with CD21 deficiency. Similar to CD19-deficient patients, IgG2 subclass usage was decreased, whereas IgA2 subclass usage was similar to HC. Somatic hypermutation was also lower in the CD21-deficient patient than in HC, but significantly higher when compared with CD19-deficient patients. These findings indicate that BCR repertoire characteristics are only minimally altered in CD21 deficiency, while there are more substantial changes in patients with CD19 deficiency, which is in line with the more severe phenotype of CD19-deficient patients.
Immunoglobulin class-switch recombination defects are rare disorders characterized by impaired production of class-switched isotypes (IgA, IgG, IgE) and are clinically commonly classified as hyper-IgM syndromes. 41 X-linked CD40 ligand (CD40L) and autosomal-recessive AID deficiency are caused by a defect in T-B-cell co-operation and an intrinsic B-cell defect, respectively. [41] [42] [43] [44] Weller et al. 45 analysed VH3-23 rearrangements in CD27 + IgM + IgD + B-cells collected from several CD40L deficiency patients and, strikingly, found evidence of somatic hypermutation in most patients, with some patients showing mutation rates similar to those seen in the same B-cell population collected from HC. Using these patients with defective T-B-cell interaction as a model, the authors concluded that the presence of mutated IgM + IgD + CD27 + B-cells in CD40L-deficient patients points towards the development and mutation of this particular B-cell subset in a CD40-independent pathway. Van Zelm et al. 39 analysed the BCR repertoire of CD40L-deficient patients and found greatly reduced somatic hypermutation in patients compared with HC. There was also reduced IgA2 subclass usage and preferential usage of self-reactive rearrangements. CD40L-deficient patients showed an increased overall transition to transversion mutation ratio and evidence of reduced base excision repair activity. Meyers et al. 46 studied features of the BCR repertoire in patients with AID deficiency using single-cell-sorted transitional and mature naive B-cells. Patients were found to exhibit characteristics that favour antibody self-reactivity, such as longer CDR3s and an increased VH4-34 gene usage. The frequency of positively charged CDR3 sequences, a feature also associated with autoimmunity, 47 was significantly higher in mature naive B-cells but not transitional B-cells from AID-deficient patients compared with HC. These findings suggest defective central and peripheral B-cell tolerance in AID-deficient patients and indicate an important role of AID in B-cell selection and the removal of self-reactive B-cells.
Overall, previous studies have shown extensive changes in the BCR repertoire of patients with CD40L and AID deficiency that agree with the severe clinical phenotype found in these patients.
Combined immunodeficiencies
Severe combined immunodeficiencies (SCID) are profound T-cell disorders characterized by absent or very low T-cell numbers. SCID patients typically present in infancy with severe bacterial, viral and opportunistic infections. X-linked SCID (X-SCID) represents the most common cause of SCID and is a result of defects in the c-chain of the interleukin (IL)-2R that leads to T-and natural killer (NK)-cell deficiency but normal B-cell numbers. 48, 49 Minegishi et al. 50 used BCR sequencing to study BCR repertoire development and VDJ recombination in these patients. CDR3 average length and D gene usage were similar between X-SCID patients and HC. There was, however, over-expression of JH3 segments and significantly lower rates of somatic hypermutation in patients compared with age-matched HC. Minegishi et al. 51 later used similar methods to analyse the VDJ junctions in the rarely occurring peripheral blood B-cells of three B-cellnegative SCID patients. There was no difference in the CDR3 length between patient and control sequences. However, the sequences from the three patients showed shorter deletions at the end of the JH segments, and fewer N nucleotide additions but more P nucleotide additions compared with HC. The frequency of productive rearrangements was similar between patients and controls. There was evidence of reduced repertoire diversity in the patients, as some clones occurred more than once. Somatic hypermutation was significantly lower in SCID patients than HC. 
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Overall, the findings in SCID patients suggest that the BCR repertoire is significantly altered and that these changes may add to the severe immunodeficiency in these patients.
Autosomal-recessive defects in recombination-activating genes (RAG) are responsible for dysfunctional VDJ recombination and result in an early arrest during B-and T-cell development. In the peripheral blood of these patients, there are typically very low T-and B-cell numbers, but normal or elevated NK-cell numbers. 52 As part of a study aiming to evaluate the immunological mechanisms underlying the clinical events associated with RAG deficiency, IJspeert et al. 53 analysed the peripheral blood and bone marrow BCR repertoire in RAG-deficient patients with combined immunodeficiency. Although the in-vitro recombination activity of RAG-deficient patients was reduced, VDJ gene usage frequency and CDR3 length distribution were broadly comparable between patients and HC. VH4-34 gene usage, a marker associated with self-reactivity (see above), was increased in two of three patients, one of which had autoimmune disease. V gene usage in kappa light chains (IgK) was normal, whereas IgK J gene usage was altered with almost no JK5 used in patient samples. This study shows that RAG deficiency leads to only small BCR repertoire alterations with the most striking feature, in the small number of individuals investigated to date, being an increase in VH4-34 usage in patients compared with HC indicating defective B-cell tolerance in these patients.
DNA ligase IV (LIG4) deficiency is a rare autosomalrecessive disorder typically associated with microcephaly, abnormal facial features, sensitivity to ionizing radiation and combined immunodeficiency of variable severity. 54 Enders et al. 55 used IgG and IgM transcripts of a young LIG4-deficient infant to perform CDR3 spectratyping and sequencing of a small number of VH3 BCR transcripts. BCR sequences from patients showed less diversity, more clonal expansions and shorter CDR3s than sequences from HC. This difference was isotype-dependent, with similar diversity of IgM sequences but decreased diversity of IgG sequences in patients compared to HC. In addition, there were more extensive nucleotide deletions among D and J elements and fewer N nucleotide insertions in BCR sequences from patients compared to HC. More recently, Felgentreff et al. 56 studied the BCR repertoire in one symptomatic and two largely asymptomatic siblings with the same compound heterozygous LIG4 mutations as part of an extensive immune phenotype analysis. Overall BCR repertoire diversity was similar between patients and controls, but clonotypical expansions were observed in two of the patients, including the symptomatic patient. There were no major differences in the V or D family usage between patients and HC, but JH3 was preferentially used in patients compared with HC. The CDR3 regions were shorter in the patients compared with HC and their amino acid composition was slightly altered (although this did not alter the hydrophobicity). No evidence for increased deletions was noted, but there were fewer N nucleotides in patient sequences compared with HC, indicative of increased usage of alternative microhomology-mediated end-joining repair. 57 Overall, these studies revealed that a diverse BCR repertoire can be generated under conditions of limited ligase IV activity. However, clonotypical expansion and favoured usage of some genes can be noted. Also, CDR3 junctions show significant abnormalities which are likely to result in structurally different antibodies, although whether this has a significant effect on antibody function against an antigen is not known.
Similar to LIG4 deficiency, XRCC4-like factor (XLF) deficiency is a rare form of autosomal-recessive disorder characterized by microcephaly, growth retardation, sensitivity to ionizing radiation and combined immunodeficiency of variable severity. 58 IJspeert et al. 59 analysed the BCR heavy and light chain repertoire of XLF-deficient patients and found a marked decrease in the number of N nucleotide additions in patients compared with HC, resulting in significantly shorter CDR3 regions. The BCR repertoire of XLF patients showed a diverse use of VDJ genes, suggesting an intact combinational diversity in these patients. In conclusion, although XLF deficiency seems to have a small effect on VDJ recombination, this study showed that XLF is involved in N nucleotide addition, which may have a potential effect on junctional and total diversity of the BCR repertoire.
DiGeorge or 22q11.2 deletion syndrome is clinically characterized by a variable phenotype typically including cardiac malformations, dysmorphic facial features, neuropsychiatric issues and variable immunodeficiency caused by thymic dysplasia or aplasia. 60, 61 Haire et al. 62 investigated the BCR repertoire of two young children with complete and partial DiGeorge syndrome, respectively. There was no difference in CDR3 sequence length or V family usage frequency between the two patients and an age-matched HC. BCR transcripts from the patient with complete DiGeorge syndrome showed no or very limited somatic hypermutation, whereas some mutations were found in transcripts from patients with partial DiGeorge syndrome. Several BCR sequences in the patients were homologous to reported autoantibody sequences. [63] [64] [65] More recently, Derfalvi et al. 66 performed next-generation BCR repertoire sequencing of patients with DiGeorge syndrome. In line with the above study, CDR3 length distribution and VH family usage was similar between patients and controls, but somatic hypermutation was diminished in patients of all age groups compared with controls. This suggests that early B-cell developmental processes remain intact in DiGeorge patients, but they have a reduced ability to diversify antibody through somatic hypermutation. Wiskott-Aldrich syndrome (WAS) is a rare X-linked PID with the classical clinical features of susceptibility to infections, microthrombocytopenia and eczema. The immunodeficiency is variable and is associated with defects affecting both the adaptive and innate immune system. 67 O'Connell et al.
68 explored immune repertoires of WAS patients and found abnormal clonotypical expansions and altered V and J usage of BCR transcripts compared with HC. None of the patients included in the study suffered from autoimmune disease, and there was only one patient with an increased usage of the VH4-34 gene segment, which is thought to be used in self-reactive antibodies. 64, 69 Patient transcripts showed an abnormal CDR3 length distribution with a deviation from the usual bell-shaped pattern and clonotypes with longer CDR3 segments. However, BCR transcripts from WAS patients had a normal rate of somatic hypermutation. Simon et al. 70 investigated possible WAS-associated B-cell defects and their link with autoimmunity by sorting transitional, naive, memory and CD19 high CD21
low B-lymphocytes followed by BCR repertoire sequencing of these B-cell subsets. Somatic hypermutation in transcripts from naive Bcells was similar to that of CD19 high CD21
low B-cells in both patients and HC. In memory B-cells, the frequency of somatic hypermutation was significantly reduced in both adult and paediatric patients with WAS compared with HC. There was an increased usage of uncommon VH genes in transitional, naive and CD19 high CD21 low B-cells of patients compared with HC, some of which are enriched in autoantibodies (VH4-34 and VH4-61). The differences noted in patients compared to HC were more marked in adults than in children, suggesting that the increased susceptibility to infection and development of autoimmunity in WAS patients is an age-dependent process. In a further study, Castiello et al. 71 analysed the VH3 and VH4 BCR repertoire of 22 WAS patients and compared the findings to age-and sex-matched HC. WAS switchedmemory B-cells showed an altered V gene usage pattern, including an increased usage of unmutated VH4-34 gene segments. Somatic hypermutation of both heavy and light chain transcripts was reduced in WAS patients compared with HC and there was altered IgG subclass usage with decreased IgG2 transcripts. The analysis of IgA transcripts showed no significant difference in the subclass usage. More recently, Kolhatkar et al. 72 sorted transitional, naive and memory B-cells from paediatric and adult WAS patients to interrogate the WAS BCR repertoire. Generally, V and J gene usage was not different between patients and HC, and there were no significant differences in CDR3 length distributions between the groups. However, WAS patients exhibited more frequent use of the VH4-34 gene in naive and IgM memory but not transitional Bcells, suggesting that WAS patients have a predisposition to produce self-reactive antibodies through a mechanism of positive selection. Somatic hypermutation was reduced in IgM memory B-cells from WAS patients compared with HC.
The findings from BCR repertoire analysis in WAS patients throughout studies show a skewing in the V and J gene usage with an increased expression of VH gene segments that are often expressed in self-reactive B-cells, which may account for the association with autoimmune diseases in these patients. The reduced usage of the IgG2 subclass, together with limited somatic hypermutation in WAS memory B-cells, indicates a reduced germinal centre activity of WAS B-cells and may be one factor driving the observed susceptibility to infection in WAS patients.
Ataxia telangectasia (AT) is an autosomal-recessive multisystem disorder characterized by progressive cerebellar ataxia, telangectasia, combined immunodeficiency and increased susceptibility to malignancies. The immune defect in AT is variable, and although most patients display several immunological abnormalities in laboratory tests, severe infections are uncommon. 73 Driessen et al. 74 investigated the BCR repertoire of AT patients with variable disease severity and found that BCR repertoire diversity was reduced in naive B-cells in AT patients compared with HC. Somatic hypermutation of isotype switched transcripts was not different between patients and HC. However, there was reduced IgG2 and IgA2 subclass usage in AT patients compared with HC. Overall, this single study showed a disturbed BCR repertoire in AT patients, including lower repertoire diversity and alterations in IgA and IgG subclass usage.
Discussion, clinical applications and future study
In this paper, we have summarized the published work on BCR repertoire sequencing in patients with primary immune disorders. It is somewhat surprising that BCR repertoires, even from severe clinical phenotypes, often only have mild abnormalities and that diversity or VDJ usage is generally preserved to some extent. This may be, in part, because most of the studied disorders do not compromise early B-cell development, so the naive B-cell repertoire develops normally. Despite the great variety of wet laboratory and analytical methods that were used in the different studies, there are several findings that are common to most investigated PIDs ( Table 2 ), suggesting that BCR repertoire characteristics may be used as an estimation for the functionality of the B-cell compartment irrespective of the underlying defect. Repertoire features that were commonly investigated include average CDR3 length, VDJ segment usage frequency, repertoire diversity and average mutation. These same characteristics have previously been shown to be conserved across individuals and specific for functionally distinct B-cell subpopulations in our own study on healthy adults. 75 BCR repertoires of PID patients generally resemble those of naive B-cells: longer CDR3, lower rates of somatic hypermutation and repertoires with restricted diversity (Table 2) . It has to be emphasized that effective data analysis and visualization are critical for rapid assessment of high-throughput sequencing data. Different types of graphs are used to emphasize the characteristics and features of a BCR repertoire (Fig. 3) .
Using BCR repertoire data, autoimmunity is commonly investigated in patients with PID by studying CDR3 features associated with self-reactive antibodies. The self- 
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NEW TOOLS AND APPLICATIONS OF IMMUNE RECEPTOR PROFILING BY HIGH-THROUGHPUT SEQUENCING BCR repertoire sequencing in PID patients reactive feature most commonly examined across studies was VH4-34 gene segment usage. VH4-34 encoded antibodies are intrinsically self-reactive. In healthy individuals, BCRs containing VH4-34 are expressed in the naive repertoire, but appear to be under-represented as B-cells develop. 76 Unmutated VH4-34 + B-cells can be detected in patients with systemic lupus erythematosus memory compartment 77 and VH4-34-expressing plasma cells appear to be clonally expanded during lupus flares.
78 VH4-34 antibodies are also associated with other conditions, such as infectious mononucleosis, cold agglutinin disease and AIDS. [79] [80] [81] However, there seems to be a beneficial role for VH4-34 encoded antibodies as they preferentially bind to commensal bacteria antigens 82 and have the ability to neutralize viral infection in vitro. 83 This indicates that in order to prevent autoimmunity, cells harbouring VH4-34 gene segments must be tightly regulated, possibly by mutating away from self-reactivity. 84 In patients with PID, where somatic hypermutation machinery is not working efficiently, B-cell repertoires are often enriched in VH4-34 + B-cells. 24, 39, 46, 53, 68, [70] [71] [72] These properties suggest that autoimmunity is an inherent feature of PIDs that are associated with dysfunctional hypermutation.
Charge and hydrophobicity of the CDR3 region are also features associated with self-reactivity. In fact, positively charged CDR3s are more likely to be self-reactive, with B-cells encoding positively charged CDR3s being removed during B-cell development. 47 Similarly, CDR3 regions containing patches of hydrophobicity are found in some autoantibodies, and B-cells expressing these antibodies are removed during development. 85 For example, in patients with XLA, CDR3 regions were found to be enriched in hydrophobic and positively charged residues 24 and Meyers et al. 46 found an increased use of positively charged residues in naive repertoires from patients with AID. These properties have not been investigated in patients with other PIDs. However, examining these features in future studies might provide better insight into the pathophysiology of PIDs that are associated with autoimmunity.
Overall, the studies that are summarized in this review show that detailed analysis of the BCR repertoire in patients with PID can improve our understanding of fundamental B-cell processes. However, the majority of studies investigating the BCR repertoire in PID have only analysed tens to a few thousand BCR sequences based on spectratyping or sequencing of individual clones. While these methods are informative and have yielded important immunological insight, they only provide a narrow view of an individual's highly diverse BCR repertoire. Current NGS approaches typically yield millions of sequences and thereby provide a much broader picture of the repertoire. 15 Larger numbers of sequences not only allow a more accurate estimation of global BCR repertoire characteristics, but also permit a more detailed analysis of similar groups of sequences that are shared across B-cell subsets, individuals and time. 16, [86] [87] [88] In contrast to previous methods, large data sets generated through NGS allow for a better assessment of the diversity of the BCR repertoire of an individual with the ability to demonstrate, e.g. restricted BCR repertoires in immunological disorders. 89 Recent methodological improvements now allow pairing of the heavy and light chain in a single B-cell and reduction in PCR and sequencing error, thus further increasing the information that can be obtained from individual samples. [90] [91] [92] [93] While there are continued improvements in experimental and computational methods, we wish to stress the importance of using a standardized experimental design and common data formats to facilitate the creation of databases and sharing of data. To detect and evaluate alterations of the BCR repertoire in PID patients, it is important to compare findings to a large group of healthy age-matched controls. Many BCR repertoire characteristics are influenced by age. 94 However, a good reference data set of the BCR repertoire of a large population of healthy controls of all different age groups is missing. Availability of such data would cover in higher resolution the variation between HCs and would allow a better assessment of abnormalities in PID patients.
There are recent efforts with the aim of using BCR repertoire sequencing as a diagnostic tool in PID patients 32 but, so far, no systematic assessment of BCR repertoire sequencing as a diagnostic has been performed.
Conclusions
Previous studies using several different methodological and analytical approaches have explored the BCR repertoire in PID patients. Findings from this research have demonstrated BCR repertoire alterations in a number of different PIDs, including several forms of predominantly antibody disorders and combined immunodeficiencies. With the use of NGS approaches, there is now the opportunity to apply immune repertoire sequencing to a large number of patients and to explore the PID immune repertoire in much more detail. Ultimately, using this technique in translational research gives the chance to add to current management of PID patients by improving diagnosis, estimating functionality of the immune system and improving assessment of prognosis.
